Are PD-1/PD-L1 Immune Checkpoint Inhibitors Completely Interchangeable in Lung Cancer? (BMIC-015)
Автор: BeaconMedIC
Загружено: 2017-11-13
Просмотров: 172
Описание:
Dr. Jack West addresses the question of whether the data with various PD-1 and PD-L1 inhibitors in lung cancer management can be viewed as a class effect and whether these immune checkpoint inhibitors should be considered interchangeable.
Visit http://BeaconMedIC.com for more media & information.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: